Skip to main content

QVT Financial LP's Form 4 filing

Roivant Sciences Ltd.ROIV · filed Nov 18, 2026

Accession no.
0001193125-26-467296
Filed
Nov 18, 2026, 5:29 PM ET
Trade date
Nov 16-17, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 10 non-derivative transactions. Open-market sales total $53.5M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
QVT Financial LPCIK 0001290162Other: Director by Deputization

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 16, 2026Common SharesSSaleDisposed−79,461$39.17−$3,112,487.3713,609,705Indirect
Nov 16, 2026Common SharesSSaleDisposed−550,280$39.17−$21,554,467.61,042,200Indirect
Nov 16, 2026Common SharesSSaleDisposed−18,927$38.99−$737,963.7313,590,778Indirect
Nov 16, 2026Common SharesSSaleDisposed−131,073$38.99−$5,110,536.27911,127Indirect
Nov 17, 2026Common SharesJOtherDisposed−2,635,169$0.00$05,806,259Indirect
Nov 17, 2026Common SharesJOtherDisposed−15,969$0.00$013,574,809Indirect
Nov 17, 2026Common SharesJOtherDisposed−385,620$0.00$0525,507Indirect
Nov 17, 2026Common SharesSSaleDisposed−75,716$38.24−$2,895,379.8413,499,093Indirect
Nov 17, 2026Common SharesSSaleDisposed−525,507$38.24−$20,095,387.680Indirect
Nov 17, 2026Common SharesSSaleDisposed−798$38.24−$30,515.525,805,461Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)